EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Ablation of symptomatic uterine fibroids with the Mirabilis system for rapid noninvasive ultrasound-guided high-intensity focused ultrasound (HIFU): a prospective observational clinical study

Tolga Tonguc, Oleksandr Savchenko, Olga Ramig, Judith M Stader, Franziska Kießling, Jim Küppers, Eva K Egger, Marcus Thudium, Patrick Martin, Wayne Poll, Hans H Schild, Rupert Conrad und 4 weitere

La radiologia medica · 10.03.2025 · 130 (5) · 629-637

DOI: 10.1007/s11547-025-01972-6 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift La radiologia medica, online erschienen am 10.03.2025. Verfasst von Tolga Tonguc und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology/Neuroradiology, University Hospital Bonn, University of Bonn, Bonn, NRW, Germany. Hauptthemen laut MEDLINE: Leiomyoma, High-Intensity Focused Ultrasound Ablation, Uterine Neoplasms, Ultrasonography, Interventional. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Bonn.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Uterine fibroids often lead to symptoms that negatively impact health-related quality of life (HRQOL). High-intensity focused ultrasound (HIFU) has emerged as a promising noninvasive treatment for reducing fibroid size and symptoms. The Mirabilis system for ultrasound (US)-guided HIFU introduces a novel technique known as ‘shell ablation’. This study evaluates the feasibility and efficacy of Mirabilis in a clinical setting, focusing on clinical outcomes. Materials and methods Sixteen patients with 23 uterine fibroids were treated with the Mirabilis system. Follow-up assessments included US and MRI at baseline, 6 weeks, 3, 6 and 9 months, and 1 year after HIFU. Changes in symptoms and QOL were evaluated using the Uterine Fibroid Symptom and HRQOL Questionnaire.

Results

A significant reduction in fibroid volume was observed after HIFU (baseline 182.1 ± 49.3 ml; 1 year: 76.0 ± 37.9 ml, p < 0.001). The symptom severity score significantly declined (baseline 57.2 ± 3.8; 1 year: 30.2 ± 4.9, p < 0.001), correlating with a significant improvement in HRQOL (baseline 47.0 ± 3.9, 1 year: 71.8 ± 5.3, p < 0.001).

Conclusion

HIFU with the portable Mirabilis system is a feasible and safe noninvasive treatment for symptomatic uterine fibroids in an outpatient setting. This approach allows efficient and rapid ablation even for large fibroids, significantly reducing fibroid volume and symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeiomyomaHigh-Intensity Focused Ultrasound AblationUterine NeoplasmsUltrasonography, InterventionalHumansFemaleProspective StudiesAdultQuality of LifeMiddle AgedTreatment OutcomeFeasibility StudiesMagnetic Resonance Imaging

Stichwörter der Autor:innen

Fibroid-associated symptomsHigh-intensity focused ultrasoundMirabilis systemMobile deviceShell ablation

Autor:innen und Institutionen

  • Department of Radiology/Neuroradiology, University Hospital Bonn, University of Bonn, Bonn, NRW, Germany.
  • Department of Nuclear Medicine, University Hospital Bonn, University of Bonn, NRW, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Department of Gynaecology and Gynaecological Oncology, University Hospital Bonn, University of Bonn, Bonn, NRW, Germany.
  • Department of Anaesthesiology, University Hospital Bonn, University of Bonn, Bonn, NRW, Germany.
  • Nalu Medical, Inc, Carlsbad, CA, USA.
  • Applied Science Management, LLC, Pismo Beach, CA, USA.

Förderung

  • Universitätsklinikum Bonn

Zitieren

APA

Tonguc, T., Savchenko, O., Ramig, O., Stader, J. M., Kießling, F., Küppers, J., Egger, E. K., Thudium, M., Martin, P., Poll, W., Schild, H. H., Conrad, R., Essler, M., Mustea, A., Strunk, H. M., & Marinova, M. (2025). Ablation of symptomatic uterine fibroids with the Mirabilis system for rapid noninvasive ultrasound-guided high-intensity focused ultrasound (HIFU): a prospective observational clinical study. La radiologia medica, 130(5), 629-637. https://doi.org/10.1007/s11547-025-01972-6

Vancouver

Tonguc T, Savchenko O, Ramig O, Stader JM, Kießling F, Küppers J, et al. Ablation of symptomatic uterine fibroids with the Mirabilis system for rapid noninvasive ultrasound-guided high-intensity focused ultrasound (HIFU): a prospective observational clinical study. La radiologia medica. 2025;130(5):629-637. doi:10.1007/s11547-025-01972-6

BibTeX
@article{Tonguc2025,
  author = {Tonguc, Tolga and Savchenko, Oleksandr and Ramig, Olga and Stader, Judith M and Kießling, Franziska and Küppers, Jim and Egger, Eva K and Thudium, Marcus and Martin, Patrick and Poll, Wayne and Schild, Hans H and Conrad, Rupert and Essler, Markus and Mustea, Alexander and Strunk, Holger M and Marinova, Milka},
  title = {Ablation of symptomatic uterine fibroids with the Mirabilis system for rapid noninvasive ultrasound-guided high-intensity focused ultrasound (HIFU): a prospective observational clinical study},
  journal = {La radiologia medica},
  year = {2025},
  volume = {130},
  number = {5},
  pages = {629--637},
  doi = {10.1007/s11547-025-01972-6}
}
Kostenlos starten →